化学科研者一站式服务平台
-
3-[(二甲基氨基)甲基]-n-[2-[4-[(羟基氨基)羰基]苯氧基]乙基]-2-苯并呋喃羧酰胺
3-[(dimethylamino)methyl]-N-[2-[4-(hydroxycarbamoyl)phenoxy]ethyl]-1-benzofuran-2-carboxamide
化合物简介
Abexinostat (INN, formerly PCI-24781) is an experimental drug candidate for cancer treatment. It is currently under development by Pharmacyclics and is in Phase II clinical trials for B-cell lymphoma. Pre-clinical study suggests the potential for treatment of different types of cancer as well.
基本信息
CAS：783355-60-2
中文别名：
英文别名：3-((dimethylamino)methyl)-N-(2-(4-(hydroxycarbamoyl)phenoxy)ethyl)benzofuran-2-carboxamide;3-[(dimethylamino)methyl]-N-{2-[4-(hydroxycarbamoyl)phenoxy]ethyl}-1-benzofuran-2-carboxamide;ABEXINOSTAT;
分子式：C21H23N3O5
分子量：397.424
精确质量：397.164
Psa：107.53
Logp：3.3879
中文别名：
英文别名：3-((dimethylamino)methyl)-N-(2-(4-(hydroxycarbamoyl)phenoxy)ethyl)benzofuran-2-carboxamide;3-[(dimethylamino)methyl]-N-{2-[4-(hydroxycarbamoyl)phenoxy]ethyl}-1-benzofuran-2-carboxamide;ABEXINOSTAT;
分子式：C21H23N3O5
分子量：397.424
精确质量：397.164
Psa：107.53
Logp：3.3879
编号系统
MDL号：MFCD10565969
物化性质
储存条件：at -20ºC 2 years
安全信息
生产方法及用途
合成路线
上游原料
下游产品
图谱
13C NMR : Predict
1H NMR : Predict
